Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome

journal contribution

posted on 2023-05-23, 00:43 authored by Chang-Hai DingChang-Hai Ding

No description available

History

Publication title

Current Opinion in Investigational Drugs

Volume

7

Issue

11

Pagination

1020-1025

Department/School

Menzies Institute for Medical Research

Place of publication

The Thomson Corporation

Socio-economic Objectives

Other health not elsewhere classified

Repository Status

Restricted

Usage metrics

University Of Tasmania

Categories

Clinical sciences not elsewhere classified

Keywords

No keyword provided

Licence

Exports